US Government Eyes 23andMe Acquisition for Potential National Security Issues
In a significant move that underscores the growing concerns regarding data privacy and national security, the United States government has indicated that the acquisition of 23andMe—a prominent consumer genetics company—could undergo a critical review. This assessment may unfold under the auspices of the Committee on Foreign Investment in the United States (CFIUS), an interagency group tasked with evaluating the implications of foreign investments in American companies.
Continue reading
Bankrupt 23andMe's DNA Data Greenlit for Sale Amid Ongoing Concerns
In a recent development, the troubled personal genomics company 23andMe has received approval to sell its DNA data, raising significant concerns among privacy advocates and stakeholders alike. This decision comes as the company navigates through bankruptcy proceedings, highlighting the precarious state of personal data ownership in the age of digital technology.
Continue reading
23andMe Resolves Data Deletion Delays Following User Surge
In a recent turn of events, genetic testing company 23andMe has announced that it has successfully addressed issues related to mass user requests for data deletion. This announcement comes after a significant spike in demands from users eager to erase their genetic information from the platform's database.
Continue reading
23andMe's Bankruptcy Puts Millions of Users' DNA Information at Risk
In a shocking development, genetic testing company 23andMe has filed for bankruptcy, raising serious concerns about the fate of the personal DNA information of its estimated 15 million users. The company, once hailed for its innovative approach to personal genomics, now finds itself grappling with financial instability, putting sensitive genetic data on the proverbial auction block.
Continue reading